Difference between revisions of "Toltrazuril5:"
(Created page with "Treatment for Coccidia infestation, Toltrazuril (Baycox) should be used in more advanced cases as it will completely eradicate the parasites'. Symptoms of Coccidia are: *Depression *Anorexia *Anemia *Signs of pain such as hunching *Pale mucous membranes *Blood or mucous in the feces *Poor coat condition *Dehydration *Weight loss or poor weight gainor growth *In severe cases of intestinal coccidiosis intussusception, convulsions or paralysis or fatality may occur *In s...") |
|||
Line 14: | Line 14: | ||
*In severe cases of intestinal coccidiosis intussusception, convulsions or paralysis or fatality may occur | *In severe cases of intestinal coccidiosis intussusception, convulsions or paralysis or fatality may occur | ||
*In severe cases of hepatic coccidiosis weakness, liver damage, and bile duct damage may occur, followed by coma | *In severe cases of hepatic coccidiosis weakness, liver damage, and bile duct damage may occur, followed by coma | ||
Toltrazuril (Baycox) treatment against coccidiosis | |||
https://pubmed.ncbi.nlm.nih.gov/25286655/ | |||
Evaluation of amprolium and toltrazuril efficacy in controlling natural intestinal rabbit coccidiosis | |||
https://pubmed.ncbi.nlm.nih.gov/29163644/ | |||
Plasma disposition of toltrazuril and its metabolites, toltrazuril sulfoxide and toltrazuril sulfone, in rabbits after oral administration | |||
https://pubmed.ncbi.nlm.nih.gov/20083354/ | |||
Eimeria stiedae: experimental infection in rabbits and the effect of treatment with toltrazuril and ivermectin | |||
https://pubmed.ncbi.nlm.nih.gov/18321485/ | |||
Pharmacokinetics of toltrazuril and its metabolites after oral and parenteral administration of novel oil-based suspension based on micro-environmental pH-modifying solid dispersion in rabbits | |||
https://pubmed.ncbi.nlm.nih.gov/34597913/ | |||
Toltrazuril mixed nanomicelle delivery system based on sodium deoxycholate-Brij C20 polyethylene ether-triton x100: Characterization, solubility, and bioavailability study | |||
https://pubmed.ncbi.nlm.nih.gov/29289823/ | |||
Comparison of toltrazuril and sulphadimethoxine in the treatment of intestinal coccidiosis in pet rabbits | |||
https://pubmed.ncbi.nlm.nih.gov/20729515/ | |||
The production and characterisation of an antibody to detect the coccidiostat toltrazuril and its metabolite ponazuril | |||
https://pubmed.ncbi.nlm.nih.gov/12790197/ | |||
Pharmacokinetics and improved bioavailability of toltrazuril after oral administration to rabbits | |||
https://pubmed.ncbi.nlm.nih.gov/20860101/ | |||
Herbal formulations as feed additives in the course of rabbit subclinical coccidiosis | |||
https://pubmed.ncbi.nlm.nih.gov/24930248/ |
Revision as of 03:37, 29 January 2022
Treatment for Coccidia infestation, Toltrazuril (Baycox) should be used in more advanced cases as it will completely eradicate the parasites'.
Symptoms of Coccidia are:
- Depression
- Anorexia
- Anemia
- Signs of pain such as hunching
- Pale mucous membranes
- Blood or mucous in the feces
- Poor coat condition
- Dehydration
- Weight loss or poor weight gainor growth
- In severe cases of intestinal coccidiosis intussusception, convulsions or paralysis or fatality may occur
- In severe cases of hepatic coccidiosis weakness, liver damage, and bile duct damage may occur, followed by coma
Toltrazuril (Baycox) treatment against coccidiosis
https://pubmed.ncbi.nlm.nih.gov/25286655/
Evaluation of amprolium and toltrazuril efficacy in controlling natural intestinal rabbit coccidiosis https://pubmed.ncbi.nlm.nih.gov/29163644/
Plasma disposition of toltrazuril and its metabolites, toltrazuril sulfoxide and toltrazuril sulfone, in rabbits after oral administration https://pubmed.ncbi.nlm.nih.gov/20083354/
Eimeria stiedae: experimental infection in rabbits and the effect of treatment with toltrazuril and ivermectin
https://pubmed.ncbi.nlm.nih.gov/18321485/
Pharmacokinetics of toltrazuril and its metabolites after oral and parenteral administration of novel oil-based suspension based on micro-environmental pH-modifying solid dispersion in rabbits https://pubmed.ncbi.nlm.nih.gov/34597913/
Toltrazuril mixed nanomicelle delivery system based on sodium deoxycholate-Brij C20 polyethylene ether-triton x100: Characterization, solubility, and bioavailability study https://pubmed.ncbi.nlm.nih.gov/29289823/
Comparison of toltrazuril and sulphadimethoxine in the treatment of intestinal coccidiosis in pet rabbits https://pubmed.ncbi.nlm.nih.gov/20729515/
The production and characterisation of an antibody to detect the coccidiostat toltrazuril and its metabolite ponazuril https://pubmed.ncbi.nlm.nih.gov/12790197/
Pharmacokinetics and improved bioavailability of toltrazuril after oral administration to rabbits https://pubmed.ncbi.nlm.nih.gov/20860101/
Herbal formulations as feed additives in the course of rabbit subclinical coccidiosis https://pubmed.ncbi.nlm.nih.gov/24930248/